Latest Insider Transactions at Aytu Biopharma, Inc (AYTU)
This section provides a real-time view of insider transactions for Aytu Biopharma, Inc (AYTU). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AYTU BIOPHARMA, INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AYTU BIOPHARMA, INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2025
|
Jarrett Disbrow Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,106
+22.71%
|
-
|
|
Oct 03
2025
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+25.72%
|
-
|
|
Oct 03
2025
|
Vivian H Liu Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+33.53%
|
-
|
|
Oct 03
2025
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,946
+12.17%
|
-
|
|
Oct 03
2025
|
Ryan J Selhorn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,743
+29.76%
|
-
|
|
Oct 03
2025
|
John Donofrio Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+42.08%
|
-
|
|
Oct 03
2025
|
Carl Dockery Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+32.85%
|
-
|
|
Oct 03
2025
|
Abhinav Jain Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+33.9%
|
-
|
|
Jun 09
2025
|
Jarrett Disbrow Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
16,666
+36.13%
|
$16,666
$1.5 P/Share
|
|
Jun 09
2025
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
66,666
+30.31%
|
$66,666
$1.5 P/Share
|
|
Mar 31
2025
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+0.88%
|
-
|
|
Feb 28
2025
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+14.77%
|
$15,000
$1.3 P/Share
|
|
Feb 05
2025
|
Ryan J Selhorn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
105
+0.65%
|
-
|
|
Dec 31
2024
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.88%
|
-
|
|
Nov 11
2024
|
Ryan J Selhorn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+46.83%
|
-
|
|
Nov 06
2024
|
Carl Dockery Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+12.56%
|
-
|
|
Nov 06
2024
|
John Donofrio Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+28.51%
|
-
|
|
Nov 06
2024
|
Abhinav Jain Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+13.64%
|
-
|
|
Nov 06
2024
|
Vivian H Liu Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+13.25%
|
-
|
|
Sep 30
2024
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+0.89%
|
-
|
|
Jun 30
2024
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.9%
|
-
|
|
Mar 31
2024
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.91%
|
-
|
|
Dec 31
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+0.92%
|
-
|
|
Sep 30
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.92%
|
-
|
|
Aug 16
2023
|
Abhinav Jain Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+44.83%
|
-
|
|
Aug 11
2023
|
Vivian H Liu Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+44.9%
|
-
|
|
Aug 11
2023
|
Abhinav Jain Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+50.0%
|
-
|
|
Aug 11
2023
|
John Donofrio Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+39.87%
|
-
|
|
Aug 11
2023
|
Carl Dockery Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+14.37%
|
-
|
|
Jun 30
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.93%
|
-
|
|
Jun 16
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
12,000
+35.36%
|
$12,000
$1.87 P/Share
|
|
Jun 14
2023
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
14,000
+16.36%
|
$14,000
$1.86 P/Share
|
|
Apr 25
2023
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
833
+7.74%
|
-
|
|
Feb 08
2023
|
Vivian H Liu Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+48.78%
|
-
|
|
Dec 21
2022
|
Gary Cantrell Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
40,000
-19.6%
|
-
|
|
Dec 21
2022
|
John Donofrio Jr. Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
187,804
-92.48%
|
-
|
|
Dec 21
2022
|
Carl Dockery Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
40,000
-21.19%
|
-
|
|
Dec 20
2022
|
Joshua R. Disbrow Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
80,000
-6.49%
|
-
|
|
Dec 19
2022
|
Greg Pyszczymuka Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+35.45%
|
$0
$0.24 P/Share
|
|
Dec 19
2022
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
112,371
+8.36%
|
$0
$0.22 P/Share
|
|
Nov 18
2022
|
Mark K Oki Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+32.14%
|
$0
$0.23 P/Share
|
|
Nov 18
2022
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
222,000
+16.55%
|
$0
$0.24 P/Share
|
|
Jul 01
2022
|
Vivian H Liu Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+50.0%
|
-
|
|
Jan 17
2022
|
Mark K Oki Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Apr 16
2021
|
Joshua R. Disbrow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+47.13%
|
-
|
|
Apr 16
2021
|
Gary Cantrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
187,804
+47.92%
|
-
|
|
Apr 16
2021
|
John Donofrio Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
187,804
+48.05%
|
-
|
|
Apr 16
2021
|
Michael Macaluso Director |
BUY
Grant, award, or other acquisition
|
Direct |
187,804
+47.44%
|
-
|
|
Apr 16
2021
|
Carl Dockery Director |
BUY
Grant, award, or other acquisition
|
Direct |
187,804
+49.87%
|
-
|
|
Apr 08
2021
|
Beth Hecht Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+41.8%
|
-
|